Ethyleneoxynitazene
Appearance
Identifiers | |
---|---|
| |
PubChem CID | |
Chemical and physical data | |
Formula | C22H26N4O3 |
Molar mass | 394.475 g·mol−1 |
3D model (JSmol) | |
| |
|
Ethyleneoxynitazene (Tetrahydrofuranitazene) is a benzimidazole derivative which has been sold as a designer drug over the internet and presumably has opioid effects. It is an analogue of etonitazene where the 4-ethoxy group attached to the benzyl ring has been cyclised round to the 3-position to form a 2,3-dihydrobenzofuran ring system. It was first reported in Estonia in February 2023,[1] subsequently in the UK in late 2023[2] and in China July 1st.[3]
See also
[edit]- Etonitazepyne
- Etomethazene
- Isotonitazene
- Methylenedioxynitazene
- List of benzimidazole opioids
- Substituted benzofuran
References
[edit]- ^ "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
- ^ "Third addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids" (PDF). Advisory Council on the Misuse of Drugs. 15 December 2023.
- ^ "Reddit - Dive into anything". www.reddit.com. Retrieved 2024-10-16.